Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
about
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerCirculating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerMesothelin targeted cancer immunotherapyAntigen-specific immunotherapy of cervical and ovarian cancerClinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.Strategies for cancer vaccine development.The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.Investigational approaches for mesothelioma.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.Expansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma.Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.New targeted therapies in pancreatic cancer.Mesothelin-targeted agents in clinical trials and in preclinical development.Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.What is recent in pancreatic cancer immunotherapy?Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancerBiological Character of RetroNectin Activated Cytokine-Induced Killer Cells.Potential targets for pancreatic cancer immunotherapeutics.Nanoprobes for hybrid SPECT/MR molecular imaging.CAR T-cell therapy for pancreatic cancer.Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells.Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses.Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
P2860
Q24622837-021980A6-EBC5-4026-A581-FDF17D1D86BEQ24651062-42CA042A-C948-40D8-AA1B-846E263ABA4FQ24656242-EE82CD2B-5DEA-4748-B787-6A1416154E68Q27488697-4851229E-DCC2-4457-83CF-AC6AF38F93ABQ30235405-029ABB6F-4CFC-4A1F-BA78-C004A28E1173Q33724878-70567696-548D-477B-9C90-36D5D07D2469Q34038338-8ACC927D-63FF-4B76-AF71-058A4B46C0E2Q34103645-DDDEE419-A53F-43C7-B1F8-7BF9855DF600Q34293068-EA9FB243-47BE-4A6B-8656-1E31EF72FF14Q34642305-BA1EE9CE-A99E-4D4B-B328-36D944E279F3Q35092711-1B7B80BB-B053-4583-9E7D-247A6DA95C69Q35244923-1E906AA9-78F1-4D8D-B481-46979A752FB0Q35550879-A62DF203-428B-4CB5-B6B8-69DFC82B51A6Q35651453-4FAFD353-F19D-4D3D-9F48-B72B12EB2B4AQ35815380-7DFDA38F-DF50-4E2B-9CD5-FC3590BB556EQ35890860-06E1A17A-2DB2-4792-A368-0EF84578E74DQ36021163-88A72E1C-6307-4AC7-BBA5-5E314A475FA5Q36639456-2D9383F6-13B0-4803-A440-8D0386B9D690Q36665335-5C06E218-DB7E-4FBE-9029-7EBDE1C2BD7CQ36857863-3F702066-6729-44C0-A653-EE2A396CC9A2Q37084335-7612A2EA-76A3-41FF-87B8-07DB617CA423Q37861220-3924E517-D86E-472B-8C37-3C5F5FFC3D3BQ38013146-C6779D2A-6238-4F16-A817-45D7585C9541Q39202440-7D7C453E-C08E-4658-850A-93EA7F90F2F8Q53581193-7C106CCE-CFAD-4591-9F3E-B3F99F66953BQ54941738-35F3D0E4-B71E-4E5A-AEED-7CCDFFB0CB36Q55001866-32C0E685-7941-4DE7-A350-132AA94C9437
P2860
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@ast
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@en
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@nl
type
label
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@ast
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@en
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@nl
prefLabel
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@ast
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@en
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@nl
P2093
P2860
P1476
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
@en
P2093
Claudia Palena
Ira Pastan
Jeffrey Schlom
Junko Yokokawa
Kwong Y Tsang
Mitchell Ho
Philip Arlen
Raffit Hassan
P2860
P304
P356
10.1158/1078-0432.CCR-05-0596
P407
P577
2005-09-01T00:00:00Z